Bacillus Calmette-Guerin Vaccine

Discontinuation Did Not Increase Risk of TB and Meningitis in China

Published in TB and Outbreaks Week, September 19th, 2000

Discontinuation of the bacillus Calmette-Guerin (BCG) vaccine did not increase the incidence of tuberculosis (TB) and meningitis in the Shun-yi county of China, researchers in that country reported.

"In Beijing, the notification of smear-positive tuberculosis has been below 20 per 100,000 since 1986 and declining," stated L.X. Zhang and colleagues from the Beijing Research Institute for Tuberculosis, and the Shun-yi Tuberculosis Center.

"In order to get a reliable estimation of annual risk of tuberculosis infection, BCG vaccination at birth has been discontinued since 1988 in Shun-yi county after establishing good case finding and high cure rates...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2000-09-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry